Abstract
Photodynamic therapy is a nonsurgical, minimally invasive technique that uses a light source to activate light-sensitive drugs or photosensitizers to treat cancer and other diseases. The effect on living organisms caused by light in the presence of a photosensitizer and oxygen is known as the photodynamic effect or photodynamic action.
Similar content being viewed by others
References and Recommended Reading
Henderson BW, Dougherty TJ: Photodynamic Therapy: Basic Principles and Clinical Applications. New York: Marcell Dekker; 1992.
Pass H: Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993, 85:443–456. Excellent review article describing the methods and use of PDT.
Svanberg K, Andersson T, Killander D: Photodynamic therapy of human skin malignancies and laser-induced fluorescence diagnostics utilizing Photofrin and 5amino levulinic acid. In Photodynamic Therapy and Biomedical Lasers. Edited by Spinelli P, Dal Fante M, Marchesini R. London: Excerpta Medica; 1992:436–440. Excellent article describing the methods and results achieved with Photofrin and ALA in the treatment of skin cancer.
Wilson BD, Mang TS, Stoll H, et al.: Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992, 128:1597–160l. The authors describe the largest series of patients with skin cancer treated with PDT. Excellent discussion of the appropriateness of the treatment and expected outcomes.
Henderson BW, Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 1992, 55:145–157. Excellent basic science discussion of the mechanism of Photofrin PDT, including its effects on oxygen radical production, tumor vascular shutdown, and immunologic activation.
Brown SB, Vernon DI, Holroyd JA, et al.: Pharmacokinetics of Photofrin in man. In Photodynamic Therapy and Biomedical Lasers. Edited by Spinelli P, Dal Fante M, Marchesi R. London: Excerpta Medica; 1992:475–479.
Bonnet R, White RD, Winfield UJ, et al.: Hydroporphyrins of the meso-tetra (hyroxyphenyl) porphyrin series as tumour photosensitizers. Biochem J 1989, 261:277–280.
Ris H-B, Altermatt JH, Interbitzi R, et al.: Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991, 64:1116–1120.
Ris H-B, Altermatt HJ, Steward CM, et al.: Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index. Int J Cancer 1993, 55:245–249.
Lui H, Kollias N, Wimberly J, et al.: A preliminary report of cutaneous photosensitivity in patients undergoing photodynamic therapy with benzoporphyrin derivative-monoacid ring A. In Photodynamic Therapy and Biomedical Lasers. Edited by Spinelli P, Dal Fante M, Marchesina R. London: Excerpta Medica; 1992:459–460.
Kelly EW, Wang KK, Swanson NN, et al.: Assessment of cutaneous phototoxicity induced by benzoporphyrin derivative and hematoporphyrin derivative. In Photodynamic Therapy and Biomedical Lasers. Edited by Spinelli P, Dal Fante M, Marchesina R. London: Excerpta Medica; 1992:493–502.
Jamieson C, Richter A, Levy JG: Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using murine tumor model. Exp Hematol 1993, 21:629–634.
Wilson BC: Photodynamic therapy: light delivery and dosage for second generation photosensitisers. In Ciba Foundation Symposium. Chichester: J Wiley; 1989, 146:60-77.
Grant WE, Hopper C, MacRobert AJ, et al.: Photodynamic therapy of oral cancer: photosensitisation with systemic amino levulinic acid. Lancet 1993, 342:147–149. The author describes the effects of oral ingestion of ALA and its effectiveness in the treatment of oral cancer.
Warloe T, Penq Q, Moan J, et al.: Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical applications of 5-aminolevulinic acid. In Photodynamic Therapy and Biomedical Lasers. Edited by Spinelli P, Dal Fante N, Marchesini R. London: Excerpta Medica; 1992:436–440.
Morgan AR, Garbo GM, Keck RW, et al.: Metallopurpurins and light: effect on transplantable rat bladder tumors and murine skin. Photochem Photobiol 1990, 51:589–592.
Yamamoto Y, Shibuya T, Okunaka K, et al.: Fiber plugging as a cause of microcirculatory occlusion during photodynamic therapy. Lasers Med Sci 1999, 14:129–135.
Fingar VH, Taber SW, Haydon PS, et al.: Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville. In Vivo 2000, 14:93–100.
Saito K, Mikuniya N, Aizawa K: Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect. Jpn J Cancer Res 2000, 91:560–565.
McMahon KS, Wieman TJ, Moore PH, et al.: Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. Cancer Res 1994, 54:5374–5379.
Taber SW, Fingar VH, Coots CT, et al.: Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Clin Cancer Res 1998, 4:2741–2746.
Allen RP: Photodynamic Therapy and Biomedical Lasers. Edited by Spinelli P, Dal Fante M, Marchesini R, et al. London: Elsevier Science; 1992.
Keller GS, Doiron DR, Fisher CU: Photodynamic therapy in otolaryngology-head and neck surgery. Arch Otolaryngol 1985, 111:758–761.
Feyh J, Goetz A, Muller W, et al.: Photodynamic therapy in head and neck surgery. J Photochem Photobiol B: Biology 1990, 7:353–358.
Feyh J, Gutmann A, Leunig A: Photodynamic therapy in head and neck surgery. Laryngol Rhino Otol 1993, 72:273–278.
Wenig BL, Kurtzman DM, Grossweiner L, et al.: Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1990, 116:1267–1270.
Grossweiner LI, Hill JH, Lobraico RV: Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial. Photochem Photobiol 1987, 46:911–917.
Freche C, DeCorbiere S: Use of photodynamic therapy in the treatment of vocal cord carcinoma. J Photochem Photobiol 1990, 6:291–296. The authors describe a large series of patients with vocal cord cancer treated with PDT and the methods used for light activation.
Schweizer VG: Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg 1990, 102:225–232.
Schweitzer VG: Photodynamic therapy: treatment of benign and malignant upper aerodigestive tract disease. SPIE Proc 1994, 2371:403–417.
Schweitzer V: Hematoporphyrin-mediated photodynamic therapy for the treatment of head and neck cancer: clinical update 1996. SPIE 1996, 2675:47–66.
Gluckman JL: Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope 1991, 101:36–42.
Grant WE, Hopper C, Speight PM, et al.: Photodynamic therapy of malignant and premalignant lesions in patients with “field cancerization” of the oral cavity. J Laryngol Otol 1993, 107:1140–1145. Excellent description of the use of PDT to treat premalignant and malignant oral field cancerization.
Biel MA: Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope 1994, l04:399–403. Description of the methods to treat laryngeal cancers with a microlens fiber.
Biel MA: Photodynamic therapy of head and neck cancers. Semin Surg Oncol 1995, 11:355–359.
Biel MA: Advances in photodynamic therapy for the treatment of head and neck neoplasia. In Advances in Otolaryngology Head and Neck Surgery, vol 15. Edited by Myers EN. St. Louis: Mosby; 2001:163–186. Excellent review of PDT to treat head and neck neoplasia. Includes a discussion of the use of fluorescence to diagnose cancers.
Biel MA: Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 1998, 108:1259–1268.
Zhao FY, Zhang KH, Ma DQ, et al.: Treatment of 510 cases of oral squamous cell carcinoma. Ann Acad Med Singapore 1989, 18:533–536.
Zhao FY, Zhang KH, Huang HN, et al.: Use of hematoporphyrin derivative as a sensitizer for radiotherapy of oral and maxillofacial tumors: a preliminary report. Lasers Med Sci 1986, 1:253–256.
Kulapaditharom B, Boonkitticharoen V: Photodynamic therapy in management of head and neck cancers and precancerous lesions. J Med Assoc Thailand 2000, 83:249–258.
Kulapaditharom B, Boonkitticharoen V: Photodynamic therapy for residual or recurrent cancer of the nasopharynx. J Med Assoc Thailand 1999, 82:1111–1117. Excellent treatment results were achieved with PDT in the treatment of T1 and T2 primary or recurrent nasopharyngeal carcinomas.
Dilkes MG, DeJode ML: m-THPC photodynamic therapy for head and neck cancer. Lasers Med Sci 1996, 11:23–29.
Dilkes MG, Alusi G, Djaezeri BJ: The treatment of head and neck cancer with photodynamic therapy: clinical experience. Rev Contemp Pharmacother 1999, 10:47–57. The authors describe results achieved with Foscan PDT and review the literature on photodynamic therapy.
Savary JF, Monnier PH, Fontolliet C, et al.: Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra(hydroxyphenyl) chlorin. Arch Otolaryngol Head Neck Surg 1997, 123:162–168.
Fan KF, Hopper C, Speight PM, et al.: Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer 1997, 73:25–32.
Hopper C: Photodynamic therapy with Foscan in primary squamous cell carcinoma of the head and neck. Oral presentation. Paper presented at the International Conference on Head and Neck Cancer. San Francisco, CA. August 2, 2000.
Biel MA: Foscan-mediated photodynamic therapy in recurrent and second primary oral cavity cancers. Oral presentation 5th International Conference on Head and Neck Cancer. San Francisco, CA,August 2, 2000.
Kubler A, Haase T, Rheinwald M, et al.: Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg 1998, 27:466–469.
Bonnett R, Djelal B: New drugs reach the clinic. Photodynamics Newsletter. 1993, 6.
Biel MA: Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. Arch Otolaryngol Head Neck Surg 1996, 122:1261–1265. Describes the methods of intraoperative adjuvant PDT of head and neck cancer at the time of surgical resection and the outcomes of patients treated in this fashion.
Cai WM, Yang Y, Zhang NW, et al.: Photodynamic therapy in the management of cancer: an analysis of 114 cases. In Methods in Porphyrin Photosensitization. Edited by Kessel D. New York: Plenum Press; 1985:13–19.
Carruth JAS, McKenzie AL: Preliminary report of a pilot study of photoradiation therapy for the treatment of superficial malignancies of the skin, head and neck. Eur J Surg Oncol 1985, 11:47–50.
Schuller DE, McCaughan JS Jr, Rock RP: Photodynamic therapy in head and neck cancer. Arch Otolaryngol 1985, 111:351–355.
Taketa C, Imakiire N: Cancer of the ear, nose and throat. In Lasers and Hematoporphyrin Derivative in Cancer. Edited by Hayata Y, Dougherty TJ. Tokyo: Igaku-Shoin; 1983:70–78.
Wile AG, Novotny J, Mason CR, et al.: Photoradiation therapy of head and neck cancer. In Porphyrin Localization and Treatment of Tumors. Edited by Doiron DR, Gomer CJ. New York: Alan R. Liss; 1984:681–691.
McCaughan JS: Photodynamic therapy of malignant tumors. Progr Clin Biol Res 1988, 278:163–169.
Zhao S, Tao Z, Xiao J, et al.: Photoradiation of animal tumors and nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1990, 99:454–460.
Buchanan RB, Carruth JA, McKenzie AL, et al.: Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol 1989, 15:400–406.
D’Cruz A, Wenig B, Iqbal A, et al.: Foscan-mediated photodynamic therapy in the palliative treatment of advanced head and neck cancer. Poster presentation 5th International Conference on Head and Neck Cancer. July 29, 2000. San Francisco, CA.
Tanaka H, Hashimoto K, Yamada I, et al.: Interstitial photodynamic therapy with rotation and reciprocating optical fibers. Cancer 2001, 91:1791–1796. The authors describe a unique method to distribute laser light deep within tumor tissue to successfully treat tongue cancer.
Schweitzer VG, Visscher D: Photodynamic therapy for treatment of AIDS-related oral Kaposi’s sarcoma. Otolaryngol Head Neck Surg 1990, 102:639–649. Excellent description of the use of PDT to treat oral Kaposi’s sarcoma.
Abramson AL, Shikowitz NJ, Mullooly VM, et al.: Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg 1992, 118:25–29. Largest and most descriptive series of the use of PDT to treat laryngeal papillomas.
Wang I, Bauer B, Andersson-Engels S, et al.: Photodynamic therapy utilizing topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and periocular skin. Acta Ophthalmol Scand 1999, 77:182–188.
Kubler AC, Haase T, Staff C: Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med 1999, 25:60–68. The authors describe the use of Foscan PDT for treating skin cancer and the excellent results achieved.
Schweitzer VG: Photofrin mediated photodynamic therapy for the treatment of aggressive head and neck nonmelanomatous skin tumors in the elderly. Laryngoscope 2001, 111:1091–8. This author describes the use of Photofrin PDT to treat recurrent invasive skin malignancies as single-modality therapy combined with surgical resection.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biel, M.A. Photodynamic therapy in head and neck cancer. Curr Oncol Rep 4, 87–96 (2002). https://doi.org/10.1007/s11912-002-0053-8
Issue Date:
DOI: https://doi.org/10.1007/s11912-002-0053-8